Product Name | NebuSelect™ Recombinant Human CD58, hFc-tag |
---|---|
Catalog Number | NBL-240886 |
Alias/Synonyms | CD58; Lymphocyte function-associated antigen 3;Ag3;CD58;LFA3 |
Appearance | see COA |
Molecule Weight | Phe29-Arg215 |
CAS | N/A |
Solubility | Water Soluble |
Storage | Short term 4℃; Long term -20℃. |
Shelf Life | 2 years |
Additional info 1 | AAH05930 |
Additional info 2 |
Catalog Numbe | Size | Price | Inventory Level | |
NBL-240886-100ug | 100ug | Inquire | Inquire | |
NBL-240886-1mg | 1mg | Inquire | Inquire | |
NBL-240886-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human CD58, hFc-tag
Catalog#:
NBL-240886
Description:
NebuSelect™ Recombinant Human CD58, hFc-tag(Cat#NBL-240886) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Phe29-Arg215.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 48.1 kDa. Due to glycosylation, the protein migrates to 65-75 kDa based on Bis-Tris PAGE result.
Target Name:
CD58; Lymphocyte function-associated antigen 3;Ag3;CD58;LFA3
Target Information:
Loss of CD58 is a common mechanism for tumor immune evasion in lymphoid malignancies. CD58 loss is known to occur due to both genetic and non-genetic causes; therefore, we hypothesized that restoring CD58 expression in lymphoma cells may be an effective treatment approach. EZH2 is involved in the epigenetic silencing of CD58 in lymphoma cells as a mechanism for tumor immune escape, and EZH2 inhibitors are able to restore epigenetically suppressed CD58 expression.
Amino Acid Sequence:
Phe29-Arg215
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.